What 19 Product Launches Taught Me: A Field Guide to Commercial Viability
The product is not the hardest part of a product launch. The hardest part is the commercial ecosystem — the network of stakeholders whose needs, behaviors, and decisions must be aligned before a product can achieve the adoption it was designed to produce.
Know Your Customer Better Than They Know Themselves: Value Proposition, Segmentation, Targeting, and Positioning in Life Sciences
The value proposition is not a statement. It is a commercial hypothesis — a testable claim about who needs what, why this product provides it better than any alternative, and why that matters to the specific customer whose behavior the organization needs to change.
The Price Is the Strategy: What Nineteen Launches Taught Me About Pricing in Life Sciences
Most organizations treat pricing as the last commercial decision because they believe the market will tell them what the product is worth. The market will — but what it reports is perceived value, not true economic value. The gap between the two is where pricing strategy lives.
Getting Through the Noise: Communication Strategy Across the Life Sciences Stakeholder Journey
In a market where every prescriber, payer, and patient is bombarded by competing messages — and where AI-generated content has compressed the signal-to-noise ratio to near zero — the question is not how much to communicate. It is how precisely.
Market Access as a Commercial Strategy Discipline: What Nineteen Launches Taught Me About the Payer Conversation
Market access is not a commercial function. It is a commercial condition — the gate through which a product's clinical profile, pricing strategy, and communication architecture must pass before any of it reaches the patient.
The Wellness Economy: Where Health Infrastructure Meets Commercial Strategy
The wellness economy is not a tenant amenity trend. It is a structural market signal that is reshaping investment and use decisions across every commercial asset class.
Read the System, Build the Evidence, Lead the Decision
The most useful strategic judgment I know didn't come from a classroom, a framework, or a single industry. It came from having to learn four completely different systems under real pressure, with real consequences each time for getting it wrong.
The Product Lifecycle Is a Brand Lifecycle. Most Organizations Build It Too Late.
Regulatory approval is a milestone. Commercial viability is a design problem. And like all design problems, it requires the right kind of thinking, applied far earlier than most organizations begin.
Health is the Ultimate Wealth
Because Florida is the third largest state in the U.S. by population with more than 23 million residents, the infrastructure to keep it healthy is noteworthy. Across 267 cities in Florida, many of its 356 hospitals across the state work together in large-scale health systems.
Healthcare Innovation and Emerging Life Science Hubs
Healthcare innovation improves global life expectancy! Have a look at where its happening and whose involved.
